Placebo Ophthalmic Solution (Vehicle)

DRUG3 trials

Sponsors

Iacta Pharmaceuticals, ORA, Inc., Eye & ENT Hospital of Fudan University

Conditions

Dry EyeDry Eye Disease (DED)Dry Eye Syndromes

Early Phase 1

JN002 for the Treatment of Dry Eye Disease

RecruitingNCT07245017

Eye & ENT Hospital of Fudan UniversityDry Eye

Start: 2025-11-24End: 2026-03-31Target: 30Updated: 2025-12-01

Phase 2

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants

TerminatedNCT05992922

Iacta PharmaceuticalsDry Eye Syndromes

Start: 2023-10-17End: 2023-12-19Updated: 2025-04-25

A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

Not yet recruitingNCT07068958

ORA, Inc.Dry Eye Disease (DED)

Start: 2025-08-01End: 2025-11-01Target: 200Updated: 2025-07-16